1 – 20 of 42
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
An overview of Clinical Quality Registries (CQRs) on gynecological oncology worldwide
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Risk factors for lymph node metastases in women with endometrial cancer : A population-based, nation-wide register study—On behalf of the Swedish Gynecological Cancer Group
(
- Contribution to journal › Article
- 2011
-
Mark
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
(
- Contribution to journal › Article
- 2005
-
Mark
Clinical trials in ovarian carcinoma : study methodology
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.20-29(
- Contribution to journal › Article
-
Mark
3rd International Ovarian Cancer Consensus Conference : outstanding issues for future consideration
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.36-38(
- Contribution to journal › Article
-
Mark
2004 consensus statements on the management of ovarian cancer : final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16 Suppl 8. p.7-12(
- Contribution to journal › Article
- 2004
-
Mark
A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer
(
- Contribution to journal › Article
- 2002
-
Mark
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer
(
- Contribution to journal › Article
- 2001
-
Mark
A systematic overview of chemotherapy effects in ovarian cancer
(
- Contribution to journal › Scientific review
-
Mark
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions
(
- Contribution to journal › Scientific review
- 2000
-
Mark
Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix
(
- Contribution to journal › Article
-
Mark
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(3). p.8-281(
- Contribution to journal › Article
- 1999
-
Mark
Indications for adjuvant radiotherapy in endometrial carcinoma
(
- Contribution to journal › Scientific review
- 1998
-
Mark
Nytt behandlingsprogram vid avancerad ovarialcancer. Tillfredsställande resultat med decentraliserad cytostatikaterapi
(
- Contribution to journal › Article
-
Mark
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis
(
- Contribution to journal › Article
-
Mark
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307(
- Contribution to journal › Article
- 1997
-
Mark
Bättre prognos vid epitelial ovarialcancer
(
- Contribution to journal › Article
-
Mark
Malignant struma ovarii' with peritoneal dissemination
(
- Contribution to journal › Letter
-
Mark
Nytt, dyrare medel mot ovarialcancer. Ar det värt sitt pris?
(
- Contribution to journal › Article
- 1996
-
Mark
Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A
(
- Contribution to journal › Article